Acerca de este artículo
Publicado en línea: 10 nov 2015
Páginas: 129 - 139
Recibido: 02 jul 2015
Aceptado: 15 sept 2015
DOI: https://doi.org/10.1515/jccm-2015-0025
Palabras clave
© 2015
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Invasive fungal infections have become a serious problem in the critically ill. One of the main reasons is the development of an immunocompromised condition. The most frequently found pathogens are Candida species. In order to provide adequate treatment, understanding this potentially life-threatening infection is mandatory. The aim of this summary is to view Candida infections from a different perspective and to give an overview on epidemiology, the range of pathophysiology from colonization to the invasive infections, and its impact on mortality. New therapeutic options will also be discussed and how these relate to current guidelines. Finally, the key issue of the choice of antifungal agents will be evaluated.